-
FENC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Fennec Pharmaceuticals (FENC)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm |
Cash burn (monthly) | 3.62 mm | (no burn) | 1.73 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 10.20 mm | n/a | 4.88 mm | n/a | n/a | n/a |
Cash remaining | 30.12 mm | n/a | 35.44 mm | n/a | n/a | n/a |
Runway (months of cash) | 8.3 | n/a | 20.4 | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 34 |
Opened positions | 16 |
Closed positions | 34 |
Increased positions | 12 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 65.75 bn |
Total shares | 14.77 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Southpoint Capital Advisors | 4.08 mm | $24.91 bn |
Essetifin SPA | 3.99 mm | $24.96 mm |
Sonic GP | 2.41 mm | $14.71 bn |
DG Capital Management | 1.63 mm | $9.99 bn |
Solas Capital Management | 1.34 mm | $8.19 bn |
STT State Street | 321.21 k | $1.96 bn |
Gendell Jeffrey L | 283.37 k | $1.73 bn |
Lion Point Capital | 170.00 k | $1.04 bn |
MS Morgan Stanley | 102.09 k | $623.74 mm |
Millennium Management | 69.33 k | $423.63 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Dec 24 | Raykov Rosty | Common shares | Option exercise | Acquire M | No | No | 2.69 | 25,000 | 67.25 k | 91,432 |
20 Dec 24 | Raykov Rosty | Stock Options options | Option exercise | Dispose M | No | No | 2.69 | 25,000 | 67.25 k | 1,675,000 |
5 Dec 24 | Raykov Rosty | Common shares | Sell | Dispose S | No | Yes | 6.04 | 796 | 4.81 k | 66,432 |
3 Dec 24 | Raykov Rosty | Common shares | Sell | Dispose S | No | Yes | 6.13 | 1,635 | 10.02 k | 67,228 |
2 Dec 24 | Rallis Chris A | Common Shares | Sell | Dispose S | No | No | 6.14 | 6,409 | 39.35 k | 52,214 |
2 Dec 24 | Rallis Chris A | Common Shares | Option exercise | Acquire M | No | Yes | 2.69 | 10,000 | 26.90 k | 58,623 |
2 Dec 24 | Rallis Chris A | Common Shares Options | Option exercise | Dispose M | No | Yes | 2.69 | 10,000 | 26.90 k | 184,698 |
2 Dec 24 | Raykov Rosty | Common shares | Grant | Acquire A | No | No | 0 | 2,431 | 0.00 | 68,863 |
2 Dec 24 | Robert Andrade | Common shares | Grant | Acquire A | No | No | 0 | 1,042 | 0.00 | 128,423 |